Total Payments
$2,759
2024 Payments
$423.29
Companies
10
Transactions
57
Medicare Patients
6,001
Medicare Billing
$678,987
Payment Breakdown by Category
Food & Beverage$2,746 (99.5%)
Education$12.50 (0.5%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $2,746 | 55 | 99.5% |
| Education | $12.50 | 2 | 0.5% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Janssen Pharmaceuticals, Inc | $1,435 | 34 | $0 (2021) |
| Novo Nordisk Inc | $339.02 | 7 | $0 (2024) |
| Abbott Laboratories | $192.29 | 3 | $0 (2024) |
| GlaxoSmithKline, LLC. | $173.78 | 4 | $0 (2024) |
| Amgen Inc. | $146.01 | 3 | $0 (2024) |
| HEARTFLOW, INC. | $145.66 | 1 | $0 (2024) |
| Edwards Lifesciences Corporation | $125.00 | 1 | $0 (2019) |
| Regeneron Healthcare Solutions, Inc. | $124.99 | 1 | $0 (2017) |
| Biosense Webster, Inc. | $59.33 | 2 | $0 (2023) |
| Novartis Pharmaceuticals Corporation | $17.65 | 1 | $0 (2023) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $423.29 | 10 | Novo Nordisk Inc ($199.22) |
| 2023 | $148.06 | 7 | Biosense Webster, Inc. ($59.33) |
| 2022 | $107.95 | 1 | Amgen Inc. ($107.95) |
| 2021 | $317.90 | 9 | Janssen Pharmaceuticals, Inc ($317.90) |
| 2020 | $176.54 | 9 | Janssen Pharmaceuticals, Inc ($176.54) |
| 2019 | $556.76 | 7 | Janssen Pharmaceuticals, Inc ($287.32) |
| 2018 | $542.80 | 10 | Janssen Pharmaceuticals, Inc ($417.80) |
| 2017 | $485.30 | 4 | Janssen Pharmaceuticals, Inc ($235.31) |
All Payment Transactions
57 individual payment records from CMS Open Payments — Page 1 of 3
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 10/23/2024 | Amgen Inc. | KRYSTEXXA (Biological) | Food and Beverage | In-kind items and services | $24.07 | General |
| Category: Inflammation/Rare Disease | ||||||
| 09/23/2024 | Novo Nordisk Inc | Rybelsus (Drug), Ozempic | Food and Beverage | In-kind items and services | $25.00 | General |
| Category: Diabetes | ||||||
| 09/09/2024 | Abbott Laboratories | FREESTYLE LIBRE 3 (Device) | Food and Beverage | In-kind items and services | $24.85 | General |
| Category: Diabetes Care | ||||||
| 06/26/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $18.30 | General |
| Category: Diabetes | ||||||
| 06/04/2024 | Amgen Inc. | Otezla (Drug), Repatha | Food and Beverage | In-kind items and services | $13.99 | General |
| Category: Inflammation | ||||||
| 04/09/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $23.07 | General |
| Category: Diabetes | ||||||
| 03/14/2024 | HEARTFLOW, INC. | FFRct (Device) | Food and Beverage | Cash or cash equivalent | $145.66 | General |
| Category: Coronary | ||||||
| 03/12/2024 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $15.50 | General |
| Category: RESPIRATORY | ||||||
| 03/07/2024 | Novo Nordisk Inc | — | Food and Beverage | In-kind items and services | $125.00 | General |
| 03/06/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $7.85 | General |
| Category: Diabetes | ||||||
| 12/22/2023 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $14.80 | General |
| Category: Diabetes | ||||||
| 10/11/2023 | Novartis Pharmaceuticals Corporation | LEQVIO (Drug) | Food and Beverage | In-kind items and services | $17.65 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 09/29/2023 | Biosense Webster, Inc. | CARTO 3 (Device) | Food and Beverage | In-kind items and services | $30.05 | General |
| Category: Cardiology | ||||||
| 09/21/2023 | GlaxoSmithKline, LLC. | AREXVY (Drug), SHINGRIX | Food and Beverage | In-kind items and services | $15.36 | General |
| Category: RESPIRATORY | ||||||
| 08/15/2023 | GlaxoSmithKline, LLC. | AREXVY (Drug), SHINGRIX | Food and Beverage | In-kind items and services | $17.92 | General |
| Category: RESPIRATORY | ||||||
| 05/24/2023 | Abbott Laboratories | FREESTYLE LIBRE 2 (Device) | Food and Beverage | In-kind items and services | $23.00 | General |
| Category: Diabetes Care | ||||||
| 05/12/2023 | Biosense Webster, Inc. | CARTO 3 (Device) | Food and Beverage | In-kind items and services | $29.28 | General |
| Category: Cardiology | ||||||
| 12/06/2022 | Amgen Inc. | Repatha (Biological) | Food and Beverage | In-kind items and services | $107.95 | General |
| Category: Cardiology | ||||||
| 10/07/2021 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Food and Beverage | In-kind items and services | $125.00 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 09/16/2021 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Food and Beverage | In-kind items and services | $21.55 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 08/26/2021 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Food and Beverage | In-kind items and services | $31.05 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 06/24/2021 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Food and Beverage | In-kind items and services | $24.79 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 06/08/2021 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Food and Beverage | In-kind items and services | $39.35 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 04/29/2021 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Food and Beverage | In-kind items and services | $20.42 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 03/08/2021 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Food and Beverage | In-kind items and services | $12.12 | General |
| Category: Cardiovascular & Metabolism | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 10 | 1,303 | 2,125 | $666,700 | $154,375 |
| 2022 | 12 | 1,423 | 2,272 | $704,141 | $162,101 |
| 2021 | 15 | 1,643 | 2,621 | $787,641 | $197,076 |
| 2020 | 15 | 1,632 | 2,617 | $430,615 | $165,434 |
Total Patients
6,001
Total Services
9,635
Medicare Billing
$678,987
Procedure Codes
54
All Medicare Procedures & Services
54 procedure records from CMS Medicare Utilization — Page 1 of 3
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Facility | 2023 | 464 | 1,092 | $358,592 | $76,254 | 21.3% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Facility | 2023 | 380 | 380 | $163,952 | $47,945 | 29.2% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Facility | 2023 | 278 | 459 | $102,177 | $21,614 | 21.2% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Facility | 2023 | 18 | 21 | $10,138 | $2,144 | 21.1% |
| 99496 | Transitional care management services for problem of high complexity | Facility | 2023 | 12 | 12 | $7,634 | $1,808 | 23.7% |
| 99443 | Telephone medical discussion with physician, 21-30 minutes | Facility | 2023 | 16 | 18 | $7,664 | $1,414 | 18.5% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Facility | 2023 | 14 | 14 | $6,426 | $1,137 | 17.7% |
| G0180 | Physician or allowed practitioner certification for medicare-covered home health services under a home health plan of care (patient not present), including contacts with home health agency and review of reports of patient status required by physicians and | Facility | 2023 | 13 | 13 | $2,249 | $546.26 | 24.3% |
| G0179 | Physician or allowed practitioner re-certification for medicare-covered home health services under a home health plan of care (patient not present), including contacts with home health agency and review of reports of patient status required by physicians a | Facility | 2023 | 12 | 16 | $2,152 | $536.48 | 24.9% |
| 93010 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report only | Facility | 2023 | 82 | 86 | $2,618 | $501.60 | 19.2% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 14 | 14 | $3,098 | $475.37 | 15.3% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Facility | 2022 | 490 | 1,168 | $379,695 | $81,451 | 21.5% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Facility | 2022 | 300 | 300 | $128,222 | $38,591 | 30.1% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Facility | 2022 | 284 | 424 | $93,356 | $19,564 | 21.0% |
| 99443 | Telephone medical discussion with physician, 21-30 minutes | Facility | 2022 | 57 | 61 | $25,742 | $4,485 | 17.4% |
| 99497 | Advance care planning, first 30 minutes | Facility | 2022 | 57 | 57 | $14,706 | $4,403 | 29.9% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Facility | 2022 | 28 | 29 | $13,862 | $3,337 | 24.1% |
| 99496 | Transitional care management services for problem of high complexity | Facility | 2022 | 17 | 18 | $11,412 | $2,773 | 24.3% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Facility | 2022 | 31 | 31 | $13,888 | $2,750 | 19.8% |
| 99495 | Transitional care management services for problem of moderate complexity | Facility | 2022 | 13 | 13 | $6,058 | $1,422 | 23.5% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 19 | 20 | $4,400 | $1,052 | 23.9% |
| G0180 | Physician or allowed practitioner certification for medicare-covered home health services under a home health plan of care (patient not present), including contacts with home health agency and review of reports of patient status required by physicians and | Facility | 2022 | 22 | 24 | $4,152 | $1,034 | 24.9% |
| G0179 | Physician or allowed practitioner re-certification for medicare-covered home health services under a home health plan of care (patient not present), including contacts with home health agency and review of reports of patient status required by physicians a | Facility | 2022 | 13 | 24 | $3,192 | $673.13 | 21.1% |
| 93010 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report only | Facility | 2022 | 92 | 103 | $5,456 | $564.52 | 10.3% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Facility | 2021 | 498 | 1,201 | $388,897 | $88,526 | 22.8% |
About Dr. Michael Dolchin, MD
Dr. Michael Dolchin, MD is a Specialist healthcare provider based in Ft Lauderdale, Florida. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 06/21/2006. The National Provider Identifier (NPI) number assigned to this provider is 1205872009.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Michael Dolchin, MD has received a total of $2,759 in payments from pharmaceutical and medical device companies, with $423.29 received in 2024. These payments were reported across 57 transactions from 10 companies. The most common payment nature is "Food and Beverage" ($2,746).
As a Medicare-enrolled provider, Dolchin has provided services to 6,001 Medicare beneficiaries, totaling 9,635 services with total Medicare billing of $678,987. Data is available for 4 years (2020–2023), covering 54 distinct procedure/service records.
Ad
Practice Information
- Specialty Specialist
- Location Ft Lauderdale, FL
- Active Since 06/21/2006
- Last Updated 11/16/2009
- Taxonomy Code 174400000X
- Entity Type Individual
- NPI Number 1205872009
Products in Payments
- XARELTO (Drug) $1,042
- INVOKANA (Drug) $392.40
- FFRct (Device) $145.66
- Mitra Clip system (Device) $144.44
- Edwards SAPIEN 3 Transcatheter Heart Valve (Device) $125.00
- SHINGRIX (Biological) $125.00
- Tresiba (Drug) $125.00
- PRALUENT ALIROCUMAB INJECTION (Biological) $124.99
- Repatha (Biological) $107.95
- Ozempic (Drug) $64.02
- CARTO 3 (Device) $59.33
- AREXVY (Drug) $33.28
- Rybelsus (Drug) $25.00
- FREESTYLE LIBRE 3 (Device) $24.85
- KRYSTEXXA (Biological) $24.07
- FREESTYLE LIBRE 2 (Device) $23.00
- LEQVIO (Drug) $17.65
- TRELEGY ELLIPTA (Drug) $15.50
- Otezla (Drug) $13.99
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Specialist Doctors in Ft Lauderdale
Martin Roche, M.d, M.D
Specialist — Payments: $781,064
Specialist $781,064
Tracey Stokes, Md, MD
Specialist — Payments: $45,870
Specialist $45,870
David Gozansky, Md, MD
Specialist — Payments: $2,843
Specialist $2,843
Rainer Sachse, Md, MD
Specialist — Payments: $2,098
Specialist $2,098
Alan Nigen, Md, MD
Specialist — Payments: $1,988
Specialist $1,988
Dr. Leonel Hernandez, Md, MD
Specialist — Payments: $1,677
Specialist $1,677